Related Experiment Video
Updated: Aug 5, 2026
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
09:58
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
Postoperative [18F]FDOPA and [18F]FDG PET Semiquantitative Scoring System for Risk Stratification in Neuroblastoma: A
Chia-Ju Liu1, Kuan-Yin Ko2, Iu-Ning Sik3
1Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Clinical Nuclear Medicine
|August 3, 2026
Summary
A new dual-tracer PET scoring system using [18F]FDOPA and [18F]FDG PET effectively stratifies risk in pediatric neuroblastoma patients post-surgery. This imaging biomarker improves prognostic accuracy for tailored treatment strategies.
Area of Science:
- Nuclear Medicine
- Oncology
- Pediatric Imaging
Background:
- Postoperative assessment of neuroblastoma is challenging.
- A semiquantitative dual-tracer PET scoring system integrating [18F]FDOPA and [18F]FDG PET was developed.
- The system aims to improve outcome stratification in pediatric neuroblastoma.
Purpose of the Study:
- To develop and validate a postoperative semiquantitative dual-tracer PET scoring system.
- To integrate [18F]FDOPA and [18F]FDG PET for outcome stratification.
- To assess the prognostic performance of the dual-tracer PET system.
Main Methods:
- Retrospective study of 46 pediatric neuroblastoma patients.
- Postoperative dual-tracer PET/CT using [18F]FDOPA and [18F]FDG.
- Visual scoring system (1-3) based on lesion uptake intensity.
- Stratification into low, intermediate, and high-risk groups.
- Survival analysis (EFS, OS) and prognostic performance quantification (C-index).
Main Results:
- Dual PET classification showed significantly different 3-year EFS and OS rates across risk groups.
- The dual PET model demonstrated superior prognostic performance over single-tracer assessment.
- Dual PET classification was an independent predictor of outcomes, adjusted for clinical factors.
Conclusions:
- Postoperative dual-tracer PET provides robust prognostic stratification in pediatric neuroblastoma.
- This imaging approach may serve as a practical biomarker for risk-adapted management.
- Dual-tracer PET enhances precision in predicting neuroblastoma patient outcomes.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...